Next Issue
Volume 15, October
Previous Issue
Volume 15, June
 
 
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..

Curr. Oncol., Volume 15, Issue 4 (August 2008) – 9 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Order results
Result details
Section
Select all
Export citation of selected articles as:
27 KiB  
Editorial
Side Effects Related to Systemic Cancer Treatment: Are We Changing the Promethean Experience with Molecularly Targeted Therapies?
by Carlo De Angelis
Curr. Oncol. 2008, 15(4), 198-199; https://0-doi-org.brum.beds.ac.uk/10.3747/co.v15i4.362 - 01 Aug 2008
Cited by 20 | Viewed by 600
Abstract
For having stolen fire and given it to mankind, Prometheus was punished by Zeus by being chained to the side of Mount Caucasus, where, every day, an eagle would eat away at his liver. [...]
Full article
6238 KiB  
Article
Cetuximab Treatment in a Patient with Metastatic Colorectal Cancer and Psoriasis
by B. Neyns, V. Meert and F. Vandenbroucke
Curr. Oncol. 2008, 15(4), 196-197; https://0-doi-org.brum.beds.ac.uk/10.3747/co.v15i4.228 - 01 Aug 2008
Cited by 17 | Viewed by 427
Abstract
Cetuximab, a monoclonal antibody directed against the epidermal growth factor receptor, has activity against colorectal cancer. Treatment is associated with skin toxicity, and the safety of cetuximab in patients with psoriasis is unknown. We report the case of a male patient with stage [...] Read more.
Cetuximab, a monoclonal antibody directed against the epidermal growth factor receptor, has activity against colorectal cancer. Treatment is associated with skin toxicity, and the safety of cetuximab in patients with psoriasis is unknown. We report the case of a male patient with stage IV colorectal cancer (CRC) and a life-long history of extensive psoriasis. This patient experienced a durable remission of his CRC and major improvement of his psoriasis during single-agent treatment with cetuximab. We conclude that, despite its known skin toxicity, cetuximab treatment can be offered to colorectal patients suffering from psoriasis. Full article
220 KiB  
Article
Sternal Resection for Recurrent Breast Cancer: A Cautionary Tale
by L. Lee, A. Keller and M. Clemons
Curr. Oncol. 2008, 15(4), 193-195; https://0-doi-org.brum.beds.ac.uk/10.3747/co.v15i4.226 - 01 Aug 2008
Cited by 7 | Viewed by 431
Abstract
The occurrence of a solitary sternal metastasis from breast cancer is relatively uncommon, and its treatment is controversial. Most case reports on the role of sternal resection in what is termed a “solitary sternal metastasis” tend to present a rather optimistic outcome. Here, [...] Read more.
The occurrence of a solitary sternal metastasis from breast cancer is relatively uncommon, and its treatment is controversial. Most case reports on the role of sternal resection in what is termed a “solitary sternal metastasis” tend to present a rather optimistic outcome. Here, we report the case of a premenopausal woman with axillary lymph node–positive, triple-negative breast cancer treated with mastectomy followed by adjuvant chemotherapy and radiation therapy. She developed a radiologically isolated sternal recurrence 3 years later, which was treated with partial sternectomy. The present case report reviews the use of sternectomy for breast cancer recurrence and highlights the need for thorough clinical and radiologic evaluation to ensure the absence of other systemic disease before extensive surgery is undertaken. Full article
59 KiB  
Article
Are Matrix Metalloproteinases Relevant Therapeutic Targets for Prostate Cancer Bone Metastasis?
by R.D. Bonfil, R. Fridman, S. Mobashery and M.L. Cher
Curr. Oncol. 2008, 15(4), 188-192; https://0-doi-org.brum.beds.ac.uk/10.3747/co.v15i4.216 - 01 Aug 2008
Cited by 8 | Viewed by 389
Abstract
After basal and squamous cell skin cancers, prostate cancer is the most frequent cancer in men in the United States, with 186,320 men estimated to be diagnosed with the disease and 28,660 expected to die from it in 2008 1. [...]
Full article
46 KiB  
Article
Healing and Survivorship: What Makes a Difference?
by H.D. Braude, N. Macdonald and M. Chasen
Curr. Oncol. 2008, 15(4), 185-187; https://0-doi-org.brum.beds.ac.uk/10.3747/co.v15i4.288 - 01 Aug 2008
Cited by 2 | Viewed by 412
Abstract
Literature demonstrating the importance of social relationships for cancer survivorship is accumulating. Building on that literature, the term “Healing Ties” refers to the scientific and popular factors supporting the idea that relationships and community are essential for healing. However, difficulties arise in assessing [...] Read more.
Literature demonstrating the importance of social relationships for cancer survivorship is accumulating. Building on that literature, the term “Healing Ties” refers to the scientific and popular factors supporting the idea that relationships and community are essential for healing. However, difficulties arise in assessing the effect of social support for survivorship. The current paper reviews the role in survivorship of social support, with respect to the explanatory model provided by neuro-oncology and psycho-neuro-immunology. Taking cognizance of the importance of social relationships, the model of cancer rehabilitation aims, through its interdisciplinary framework, to restore a sense of well-being and to facilitate healing by optimizing the capability for full social relationships and engagement with the world. Full article
64 KiB  
Article
Defining the Optimal Treatment Strategy for Localized Prostate Cancer Patients: A Survey of Ongoing Studies at the National Cancer Institute of Canada Clinical Trials Group
by W.R. Parulekar, M. McKenzie, K.N. Chi, L. Klotz, C. Catton, M. Brundage, K. Ding, A. Hiltz, R. Meyer and F. Saad
Curr. Oncol. 2008, 15(4), 179-184; https://0-doi-org.brum.beds.ac.uk/10.3747/co.v15i4.257 - 01 Aug 2008
Cited by 5 | Viewed by 701
Abstract
The designation “clinically localized prostate cancer” comprises a group of biologically heterogeneous tumours with different growth rates and risks of relapse. Because prostate cancer is primarily a disease of older men, treatment selection must take into account the prognosis of the tumour, patient [...] Read more.
The designation “clinically localized prostate cancer” comprises a group of biologically heterogeneous tumours with different growth rates and risks of relapse. Because prostate cancer is primarily a disease of older men, treatment selection must take into account the prognosis of the tumour, patient age, comorbidities, side effects of treatment, and patient preferences. Clinical trials must identify the various prognostic groups and test the appropriate treatment strategies within these subgroups. Full article
206 KiB  
Article
The Economic Impact on Families When a Child Is Diagnosed with Cancer
by B. Miedema, J. Easley, P. Fortin, R. Hamilton and M. Mathews
Curr. Oncol. 2008, 15(4), 173-178; https://0-doi-org.brum.beds.ac.uk/10.3747/co.v15i4.260 - 01 Aug 2008
Cited by 81 | Viewed by 1456
Abstract
Objective: In a study conducted in New Brunswick and Newfoundland and Labrador, we examined the economic impact on families caring for a child with cancer. Methods: We undertook semi-structured interviews with 28 French and English families with a child diagnosed with [...] Read more.
Objective: In a study conducted in New Brunswick and Newfoundland and Labrador, we examined the economic impact on families caring for a child with cancer. Methods: We undertook semi-structured interviews with 28 French and English families with a child diagnosed with cancer in the last 10 years. Results: Families who care for a child with cancer incur considerable costs during the diagnostic, treatment, and follow-up care phases of the disease. Four major themes emerged from this qualitative study as contributing factors for these expenses: necessary travel; loss of income because of a reduction or termination of parental employment; out-of-pocket treatment expenses; and inability to draw on assistance programs to supplement or replace lost income. In addition, many of the decisions with regard to the primary caregiver were gendered. Typically, the mother is the one who terminated or reduced work hours, which affected the entire family’s financial well-being. Conclusions: For families with children diagnosed with cancer, financial issues emerged as a significant concern at a time when these families were already consumed with other challenges. This economic burden can have long-term effects on the financial security, quality of life, and future well-being of the entire family, including the siblings of the affected child, but in particular the mother. Financial assistance programs for families of seriously ill children need to be revisited and expanded. Full article
389 KiB  
Article
Contemporary Management of Stage I Testicular Seminoma: A Survey of Canadian Radiation Oncologists
by R. Samant, I. Alomary, P. Genest and L. Eapen
Curr. Oncol. 2008, 15(4), 168-172; https://0-doi-org.brum.beds.ac.uk/10.3747/co.v15i4.213 - 01 Aug 2008
Cited by 2 | Viewed by 460
Abstract
Recently published studies clearly indicate that there are now several acceptable options for managing stage I testicular seminoma patients after orchiectomy. We therefore decided to survey Canadian radiation oncologists to determine how they currently manage such patients and to compare the results with [...] Read more.
Recently published studies clearly indicate that there are now several acceptable options for managing stage I testicular seminoma patients after orchiectomy. We therefore decided to survey Canadian radiation oncologists to determine how they currently manage such patients and to compare the results with previous surveys. Our results demonstrate that adjuvant single-agent chemotherapy is being considered as an option by an increasing proportion of radiation oncologists (although it is not considered the preferred option), the routine use of radiotherapy is declining, and surveillance is becoming increasingly popular and is recommended most often. Full article
30 KiB  
Editorial
The Integrative Oncology Supplement—A Paradigm for Both Patient Care and Communication
by S.M. Sagar
Curr. Oncol. 2008, 15(4), 166-167; https://0-doi-org.brum.beds.ac.uk/10.3390/curroncol15040004 - 01 Aug 2008
Cited by 5 | Viewed by 308
Abstract
Integrative oncology is both a science and a philosophy that focuses on the complexity of[...] Full article
Previous Issue
Next Issue
Back to TopTop